Infleqtion, Inc. (“Infleqtion”), a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced the completion of its previously announced business combination with Churchill Capital Corp X (Nasdaq: CCCX) (“Churchill X”), a special purpose acquisition company.
Churchill Capital Corp X (“Churchill X”) (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business combination with Infleqtion, Inc. (“Infleqtion”), a global leader in quantum sensing and quantum computing powered by neutral-atom technology.
Infleqtion, a global leader in quantum sensing and quantum computing, develops atom-based quantum technology for commercial and government applications. Infleqtion is proud to announce the induction of Dr. Dana Anderson into the National Academy of Engineering (NAE) for contributions to optical quantum engineering of ultracold atoms. Infleqtion recently announced plans to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Churchill Capital Corp X (NASDAQ: CCCX) shares are trading higher Tuesday morning as investors react to fresh momentum around its merger target Infleqtion.
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced its role as a collaborator on NASA’s Quantum Gravity Gradiometer Pathfinder (QGGPf) mission. Led by NASA’s Jet Propulsion Laboratory (JPL), the mission will fly the first quantum sensor capable of measuring the Earth's gravitational field and its gradients; signals that are used today to monitor mass dynamics on the planet's surface. The quantum instrument will be aboard a dedicated satellite in low Earth orbit (LEO). This program follows Infleqtion’s announcement to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion, a global leader in quantum computing and quantum sensing, today announced it has executed its contract with the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E), formally launching development under its $6.2 million Enhancing Neutral-atom Computers for Optimizing Delivery of Energy (ENCODE) project. This program, which includes key collaborations with Argonne National Laboratory, the National Laboratory of the Rockies (NRL), EPRI, and ComEd, is the first quantum project for the department focusing on advancing the application of quantum-enhanced computational methods to revolutionize energy grid optimization. This announcement follows Infleqtion’s plans to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion, formerly ColdQuanta, is an under-the-radar quantum computing and sensing company set to go public in the coming weeks via SPAC merger with well-known Wall Street dealmaker Michael Klein's Churchill Capital Corp X (NASDAQ:CCCX).
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced a successful live demonstration with Quantum Corridor showing how critical digital infrastructure can stay precisely synchronized without relying on GPS. Quantum Corridor is a quantum-safe, ultra-fast, and highly secure fiber-optic network in the Midwest enabling next-generation communication. The demonstration was conducted across 21.8 kilometers of live urban fiber between Chicago’s ORD10 Data Center (350 Cermak) and the Digital Crossroad Data Center (100 Digital Crossroad Drive) in Hammond, IN. The announcement follows Infleqtion’s plans to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced that its quantum software team, together with collaborators at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge, a global program focused on demonstrating quantum-enabled solutions for human health. The news comes as Infleqtion prepares to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Churchill Capital Corp X (“Churchill X”), a special purpose acquisition company, today announced Churchill X’s intent to transfer the listing of its Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”) and public warrants (the “CCX Warrants”) (each, the Common Stock and Warrants following transactions contemplated by the Business Combination, as defined below), from the Nasdaq Stock Market LLC (“Nasdaq”) to the New York Stock Exchange (the “NYSE”) following, and subject to the completion of, its previously announced business combination with ColdQuanta, Inc. (d/b/a Infleqtion) (“Infleqtion”, and such related transactions, the “Business Combination”). In connection with the Business Combination, Churchill X will transfer its registration by way of continuation from the Cayman Islands to the State of Delaware and: (1) each Class A Ordinary Share will automatically convert, on a one-for-one basis, into one share of common stock of Churchill X (the “Common Stock”); and (2) each of the issued and outstanding CCX Warrants will automatically convert into a warrant (“Warrant”) to acquire a corresponding number of shares of the Common Stock, on a one-for-one basis. In addition, prior to the closing of the Business Combination, each unit of CCX sold in its initial public offering (“Unit”) will be separated into one Class A Ordinary Share and one-quarter of one CCX Warrant. The Units will no longer be listed on Nasdaq following the closing of the Business Combination.
Infleqtion, a global leader in quantum sensing and quantum computing, announced research results from a collaboration with the University of Wisconsin–Madison that demonstrate a more reliable way to measure individual quantum bits, or qubits, without interrupting ongoing circuits. The work addresses one of the central challenges in quantum computing by enabling faster computation cycles while preserving fragile quantum states. This announcement follows Infleqtion’s plans to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion (the “Company”), a global leader in neutral atom-based quantum computing and quantum sensing, powered by neutral-atom technology, announced the appointment of Dave Kresse as Vice President of Commercial Solutions, effective immediately. Kresse brings more than 30 years of experience building and scaling technology businesses, leading global teams and forging commercial partnerships. He joins Infleqtion after the company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ: CCCX) (“Churchill X”), a special purpose acquisition company.
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced the appointment of J. Eric Bjornholt to its Board of Directors effective immediately. Bjornholt brings more than three decades of finance and advisory experience, joining Infleqtion as the Company advances toward its planned public listing. The company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ: CCCX) (“Churchill X”), a special purpose acquisition company.
Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced that its joint registration statement on Form S-4 (the “Registration Statement”) with Churchill Capital Corp X (NASDAQ: CCCX) (“Churchill X”), filed with Securities and Exchange Commission (the “SEC”) in connection with the proposed business combination between Infleqtion and Churchill X, was declared effective by the SEC on January 23, 2026. This represents an important step in the process toward completion of the previously disclosed proposed business combination between Infleqtion and Churchill X. Churchill X has set a meeting date of February 12, 2026 for its extraordinary general meeting to approve the proposed business combination and related matters.
Infleqtion (the “Company”), a global leader in neutral atom-based quantum technology, announced the appointment of Colin Sullivan MBE as Managing Director of Infleqtion UK effective immediately. In this role, he will spearhead Infleqtion’s UK operations, advancing its mission to transform quantum research into deployable capabilities for defence, security, and commercial sectors. Sullivan is joining Infleqtion after the company announced in September that it plans to go public through a business combination with Churchill Capital Corp X (NASDAQ: CCCX) (“Churchill X”), a special purpose acquisition company.
Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and Exchange Commission of their joint registration statement on Form S-4 (the “Registration Statement”) in connection with their proposed business combination. The Registration Statement includes a preliminary proxy statement/prospectus and has not yet been declared effective. The information contained therein is subject to change. The filing follows the confidential submission of a draft registration statement on October 29, 2025 and represents a step in the process toward completion of the previously disclosed proposed business combination between Infleqtion and Churchill Capital Corp X (“Churchill X”).
Infleqtion, a global leader in neutral atom–based quantum technology, will participate in the quantum conference track at CES 2026, taking place January 7-10 in Las Vegas. [As the world's most influential technology event,] CES brings together tens of thousands of innovators, developers, and industry leaders to explore the latest breakthroughs shaping the future of consumer technology. Infleqtion plans to go public through a merger with Churchill Capital Corp X (NASDAQ: CCCX).
